Leerink Partners Initiates Coverage On Immunocore Hldgs with Outperform Rating, Announces Price Target of $74
Immunocore Holdings Plc Sponsored ADR 0.00%
Immunocore Holdings Plc Sponsored ADR IMCR | 33.31 | 0.00% |
Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:
IMCR) with a Outperform rating and announces Price Target of $74.